Page last updated: 2024-11-04

tetracaine and Acquired Immunodeficiency Syndrome

tetracaine has been researched along with Acquired Immunodeficiency Syndrome in 1 studies

Tetracaine: A potent local anesthetic of the ester type used for surface and spinal anesthesia.
tetracaine : A benzoate ester in which 4-N-butylbenzoic acid and 2-(dimethylamino)ethanol have combined to form the ester bond; a local ester anaesthetic (ester caine) used for surface and spinal anaesthesia.

Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pankhurst, CL1
Lewis, DA1
Clark, DT1

Trials

1 trial available for tetracaine and Acquired Immunodeficiency Syndrome

ArticleYear
Prophylactic application of an intra-alveolar socket medicament to reduce postextraction complications in HIV-seropositive patients.
    Oral surgery, oral medicine, and oral pathology, 1994, Volume: 77, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anesthetics, Local; Aspirin; Chlortetracycline; Dental Ca

1994